Complete FDA and NHTSA recall records dated in January 2024.
These records include useful source details for the selected month.
Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Chemical contamination: Presence of benzene
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
